A new study looking at the MS landscape

A clinical research study of an investigational drug for people with multiple sclerosis is now enrolling.


About this study

The SPI2 Study will assess the safety and effectiveness of an investigational drug in men and women with progressive multiple sclerosis (MS). If you are 18–65 years of age, been diagnosed with progressive MS and have not experienced a relapse in the past 24 months, you may be able to take part*.

*Other medical criteria must be met before you can join the study, which will be assessed by the study team.

Ready to get started?

Find a study centre